The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Oncology; Bayer; Ipsen; Janssen; Novartis; Pfizer; Sanofi
Research Funding - Janssen (Inst); Sanofi (Inst)
A phase II trial of cemiplimab alone or in combination with standard of care chemotherapy in locally advanced or metastatic penile carcinoma (EPIC Trial).
 
Emily Renninson
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Amarnath Challapalli
Consulting or Advisory Role - Merck; Regeneron; Sanofi
Speakers' Bureau - Astellas Oncology; Bayer; Eisai; EUSA Pharma; Ipsen; Janssen; Merck; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; EUSA Pharma; Ipsen; Janssen; Merck; Novartis; Pfizer; Sanofi
 
Emily Foulstone
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Alicia Bravo
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Alexandra Soundy
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Mark Callaway
Consulting or Advisory Role - AstraZeneca
 
Alastair Thomson
Consulting or Advisory Role - MSD; Novartis
Speakers' Bureau - Genomic Health; Lilly; Novartis; Roche
Travel, Accommodations, Expenses - Astellas Pharma; BMS; EUSA Pharma; Ipsen; MSD
 
Constantine Alifrangis
No Relationships to Disclose
 
Mehran Afshar
No Relationships to Disclose
 
Anna Tran
No Relationships to Disclose
 
Balaji Venugopal
Honoraria - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck; MSD Oncology; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Pfizer/EMD Serono
Speakers' Bureau - Eisai; Janssen Oncology; MSD Oncology; Pfizer
Research Funding - Calithera Biosciences (Inst); Ipsen (Inst); MSD Oncology (Inst); Pfizer/EMD Serono (Inst)
Travel, Accommodations, Expenses - EUSA Pharma; Ipsen
 
Paul White
No Relationships to Disclose
 
Emil Cano
No Relationships to Disclose
 
Anand Sharma
No Relationships to Disclose
 
Amit Bahl
No Relationships to Disclose